Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Hepatology Communications
|
December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Medicine
|
June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
Nomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Science (New York, N.Y.)
|
March 10, 2021
SARS-CoV-2 within-host diversity and transmission
Katrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Lancet (London, England)
|
May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial
Graham S Cooke, Le Manh Hung, Barnaby Flower, et al.
The Lancet. Microbe
|
November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
Adrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Gut
|
July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Stephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
JCI Insight
|
February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ane Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Yanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
Nature Communications
|
April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Hepatology Communications
|
December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.
Nature Medicine
|
June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
Nomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Science (New York, N.Y.)
|
March 10, 2021
SARS-CoV-2 within-host diversity and transmission
Katrina A Lythgoe, Matthew Hall, Luca Ferretti, et al.
Lancet (London, England)
|
May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial
Graham S Cooke, Le Manh Hung, Barnaby Flower, et al.
The Lancet. Microbe
|
November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
Adrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Gut
|
July 5, 2022
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Stephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.
JCI Insight
|
February 22, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ane Ogbe, Matthew Pace, Mustapha Bittaye, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Broad and strong memory CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Yanchun Peng, Alexander J Mentzer, Guihai Liu, et al.
The Lancet. HIV
|
June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, et al.
Nature Communications
|
April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Page
of 10